BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31216476)

  • 21. PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
    Johansson JA; Marie KL; Lu Y; Brombin A; Santoriello C; Zeng Z; Zich J; Gautier P; von Kriegsheim A; Brunsdon H; Wheeler AP; Dreger M; Houston DR; Dooley CM; Sims AH; Busch-Nentwich EM; Zon LI; Illingworth RS; Patton EE
    Dev Cell; 2020 Aug; 54(3):317-332.e9. PubMed ID: 32652076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
    Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
    Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
    Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDX3X, the X homologue of AZFa gene DDX3Y, expresses a complex pattern of transcript variants only in the male germ line.
    Rauschendorf MA; Zimmer J; Ohnmacht C; Vogt PH
    Mol Hum Reprod; 2014 Dec; 20(12):1208-22. PubMed ID: 25208899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MITF in melanoma: mechanisms behind its expression and activity.
    Hartman ML; Czyz M
    Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Viral Protein K7 Inhibits Biochemical Activities and Condensate Formation by the DEAD-box Helicase DDX3X.
    Venus S; Tandjigora K; Jankowsky E
    J Mol Biol; 2023 Oct; 435(19):168217. PubMed ID: 37517790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
    Vachtenheim J; Novotná H
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical Differences and Similarities between the DEAD-Box Helicase Orthologs DDX3X and Ded1p.
    Sharma D; Putnam AA; Jankowsky E
    J Mol Biol; 2017 Nov; 429(23):3730-3742. PubMed ID: 29037760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
    Sestáková B; Ondrusová L; Vachtenheim J
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
    Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M
    J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MITF, the Janus transcription factor of melanoma.
    Koludrovic D; Davidson I
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
    Vivas-García Y; Falletta P; Liebing J; Louphrasitthiphol P; Feng Y; Chauhan J; Scott DA; Glodde N; Chocarro-Calvo A; Bonham S; Osterman AL; Fischer R; Ronai Z; García-Jiménez C; Hölzel M; Goding CR
    Mol Cell; 2020 Jan; 77(1):120-137.e9. PubMed ID: 31733993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation.
    Valentin-Vega YA; Wang YD; Parker M; Patmore DM; Kanagaraj A; Moore J; Rusch M; Finkelstein D; Ellison DW; Gilbertson RJ; Zhang J; Kim HJ; Taylor JP
    Sci Rep; 2016 May; 6():25996. PubMed ID: 27180681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
    Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
    Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The X-Linked Helicase DDX3X Is Required for Lymphoid Differentiation and MYC-Driven Lymphomagenesis.
    Lacroix M; Beauchemin H; Fraszczak J; Ross J; Shooshtarizadeh P; Chen R; Möröy T
    Cancer Res; 2022 Sep; 82(17):3172-3186. PubMed ID: 35815807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.
    Oh S; Flynn RA; Floor SN; Purzner J; Martin L; Do BT; Schubert S; Vaka D; Morrissy S; Li Y; Kool M; Hovestadt V; Jones DT; Northcott PA; Risch T; Warnatz HJ; Yaspo ML; Adams CM; Leib RD; Breese M; Marra MA; Malkin D; Lichter P; Doudna JA; Pfister SM; Taylor MD; Chang HY; Cho YJ
    Oncotarget; 2016 May; 7(19):28169-82. PubMed ID: 27058758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.